Rapid Comfort Non Aspirin

Description

145R LSS Non-Aspirin 325 mg, marketed under the brand name Rapid Comfort™, contains 325 mg of acetaminophen as its active ingredient. This formulation is presented in the form of film-coated tablets, designed for easy swallowing. The product is packaged in tamper-evident unit dose packets, with a total of 100 tablets organized in 50 packs of 2 tablets each. The active ingredient profile is comparable to that of Tylenol®. Rapid Comfort™ is a registered trademark of McNeil Consumer.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with headache, muscular aches, minor arthritis pain, common cold, toothache, and menstrual cramps. Additionally, it is indicated for the reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are instructed to take 2 tablets every 4 to 6 hours as needed. It is essential not to exceed a total of 12 tablets within a 24-hour period to avoid potential overdose.

For children under 12 years of age, this medication is contraindicated and should not be administered.

Contraindications

Use of this product is contraindicated in the following situations:

The product should not be used concurrently with any other medication containing acetaminophen, whether prescription or nonprescription. If there is uncertainty regarding the presence of acetaminophen in a medication, consultation with a healthcare professional is advised.

Additionally, the product should not be used for pain relief for more than 10 days unless directed by a physician. Similarly, it should not be used for fever for more than 3 days unless specifically instructed by a healthcare provider.

Warnings and Precautions

Severe liver damage may occur with the use of this product, which contains acetaminophen. Healthcare professionals should advise patients that the risk of liver injury increases significantly if they exceed the maximum daily dosage of 12 tablets within a 24-hour period, use other medications containing acetaminophen concurrently, or consume three or more alcoholic drinks daily while taking this product.

Patients with a history of liver disease should be cautioned to consult a physician prior to use. Additionally, individuals taking the anticoagulant warfarin should seek guidance from a healthcare provider or pharmacist before using this product, as potential interactions may occur.

In the event of an accidental overdose, it is imperative to seek emergency medical assistance or contact a Poison Control Center immediately. Prompt intervention is crucial for both adults and children, even in the absence of noticeable symptoms.

Patients should be instructed to discontinue use and consult a physician if symptoms do not improve, if new symptoms arise, if pain or fever persists or worsens, or if there is any presence of redness or swelling.

Side Effects

Patients using this product should be aware of the potential for serious adverse reactions, particularly concerning liver health. This product contains acetaminophen, and severe liver damage may occur if patients exceed the maximum daily dosage of 12 tablets within a 24-hour period, take it in conjunction with other medications containing acetaminophen, or consume three or more alcoholic drinks daily while using this product.

It is crucial for patients to avoid using this product in combination with any other drug containing acetaminophen, whether prescription or nonprescription. Patients should also refrain from using this product for more than 10 days for pain or more than 3 days for fever unless directed by a healthcare professional.

Patients with pre-existing liver disease should consult a doctor before using this product. Additionally, those taking the blood-thinning medication warfarin should seek advice from a doctor or pharmacist prior to use.

Patients are advised to discontinue use and consult a healthcare professional if symptoms do not improve, if new symptoms arise, if pain or fever persists or worsens, or if there is any redness or swelling present.

In the event of an accidental overdose, it is imperative to seek medical assistance or contact a Poison Control Center immediately. Prompt medical attention is critical for both adults and children, even if no signs or symptoms are initially apparent.

Drug Interactions

Patients taking the anticoagulant warfarin should consult with a healthcare professional prior to using this medication. The interaction between this drug and warfarin may necessitate careful monitoring of coagulation parameters to ensure therapeutic efficacy and minimize the risk of adverse effects. Adjustments to the dosage of either medication may be required based on clinical judgment and patient response.

Packaging & NDC

Below are the non-prescription pack sizes of Rapid Comfort Non Aspirin (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Children under 12 years of age should not be administered this medication. For adolescents aged 12 years and older, the recommended dosage is 2 tablets every 4 to 6 hours as needed, with a maximum limit of 12 tablets within a 24-hour period. Caution is advised to ensure adherence to the dosing guidelines to prevent potential overdose.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, as it contains acetaminophen, which is associated with the risk of severe liver damage. It is critical that patients do not exceed the maximum daily dosage of 12 tablets within a 24-hour period. Additionally, patients should avoid concomitant use with other medications containing acetaminophen, as this may further increase the risk of liver injury.

Patients with compromised liver function are advised to consult a healthcare professional prior to using this product, particularly if they have a history of liver disease. Furthermore, it is recommended that patients limit alcohol consumption to fewer than three alcoholic drinks per day while using this product to mitigate the risk of liver damage. Regular monitoring of liver function may be warranted in patients with existing liver conditions to ensure safety and efficacy during treatment.

Overdosage

In the event of an accidental overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial for both adults and children, even in the absence of noticeable signs or symptoms.

Healthcare professionals are advised to remain vigilant and proactive in managing potential overdose situations. The absence of symptoms does not preclude the possibility of serious adverse effects, and timely medical evaluation can be essential in mitigating risks associated with overdose.

Nonclinical Toxicology

If pregnant or breast-feeding, it is advised to consult a health professional before use. No specific non-teratogenic effects have been identified. Additionally, there are no detailed findings related to nonclinical toxicology or animal pharmacology and toxicology available.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize the potential risks associated with overdose. In the event of an accidental overdose, patients should be instructed to seek medical help or contact a Poison Control Center immediately. Prompt medical attention is critical for both adults and children, even if no signs or symptoms are initially apparent.

Storage and Handling

The product is supplied in tamper-evident sealed packets to ensure safety and integrity. It is essential to avoid using any packets that are opened or torn.

For optimal storage, the product should be maintained at room temperature, specifically within the range of 59ºF to 86ºF (15ºC to 30ºC). Proper adherence to these storage conditions is crucial to preserve the product's efficacy and safety.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a healthcare professional prior to use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Rapid Comfort Non Aspirin, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)